SynAct Pharma has announced that its Chief Financial Officer, Patrik Renblad has resigned and will move to a new assignment outside of the company.
He will leave SynAct by the end of July, 2023, at the latest.
Patrik Renblad joined SynAct in 2021 and has during his tenure been instrumental in